FHACT® takes the guesswork out of cervical cancer testing
CGI’s FISH-based HPV-Associated Cancer Test (FHACT®) is the only four color FISH probe available for cervical cancer testing. When used as an additional triage before colposcopy, FHACT® can help identify those women with low-grade or undetermined lesions (ASCUS/LSIL) who are likely to progress to more advanced cervical disease. By reducing the number of unnecessary colposcopies performed, FHACT® can help reduce healthcare costs, relieve patient anxiety, and prevent complications associated with over treatment.
No Resampling Necessary
FHACT® is a non-invasive test and is performed utilizing leftover liquid-based cytology and conventional Pap smears, so no resampling is necessary.
Include FHACT® as an additional triage before referral for colposcopy.
FHACT® is a non-invasive test and is performed utilizing leftover liquid-based cytology and conventional Pap smears, so no resampling is necessary. To learn more about FHACT,® please visit www.cgifhact.com.
CGI’s ExpandDx Collaborative Oncology Testing
Fluorescence in situ hybridization (FISH) is used to detect chromosomal aberrations such as DNA copy number changes (gain/loss) and rearrangements (translocation/break apart). FISH is a method of choice for diagnosis, prognosis, and treatment response prediction for a number of hematological and solid tumor cancers.